Bridging the dimensions: multi-parameter optimisation of 2D and 3D SAR

webinar

Tue, 28 Jan 2020, 17:00 CET (Berlin)

Dr. Matthew Segall, CEO at Optibrium Ltd, Cambridge, United Kingdom

Bridging the dimensions: multi-parameter optimisation of 2D and 3D SAR

There has typically been a divide between tools for three-dimensional (3D) structure-based design and those for analysis of structure-activity relationships (SAR) based on two-dimensional (2D) compound structures. Seamless integration between these approaches would enable all the available structural knowledge to be used to guide the efficient design of high quality, active compounds.

We have been working together with BioSolveIT to seamlessly integrate their unique SeeSAR™ technology, including pose generation, HYDE scoring and torsion angle analysis within our StarDrop™ platform. In this webinar, we will illustrate how 2D analyses of SAR, such as activity cliff detection and matched molecular pair analyses, can be seamlessly linked in a highly visual way with related 3D structural information to understand and rationalize this SAR. Furthermore, information from 2D models of key physicochemical and absorption, distribution, metabolism, elimination and toxicity (ADMET) properties can be combined with 3D docked poses and affinity estimates. The influence of each atom or functional group on these properties can be highlighted and combined with visualization of the atomistic contributions to binding affinity, enabling development of optimization strategies that balance potency with the ADMET properties required in a safe and efficacious drug.

These combined capabilities enable the efficient design of compounds with improved target affinity in a truly multi-parameter optimization environment.

Current news

category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on
A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on